HK1041434A1 - 抗病毒藥物和乙型肝炎疫苗的聯合 - Google Patents

抗病毒藥物和乙型肝炎疫苗的聯合

Info

Publication number
HK1041434A1
HK1041434A1 HK02101211.9A HK02101211A HK1041434A1 HK 1041434 A1 HK1041434 A1 HK 1041434A1 HK 02101211 A HK02101211 A HK 02101211A HK 1041434 A1 HK1041434 A1 HK 1041434A1
Authority
HK
Hong Kong
Prior art keywords
vaccine
hepatitis
combination
antiviral agents
antiviral
Prior art date
Application number
HK02101211.9A
Other languages
English (en)
Inventor
F Atkinson Gillian
J Boon R
g vandepapeliere P
A C Wettendorff M
Original Assignee
Smithkline Beecham Biologicals S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biologicals S A filed Critical Smithkline Beecham Biologicals S A
Publication of HK1041434A1 publication Critical patent/HK1041434A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK02101211.9A 1999-01-12 2002-02-19 抗病毒藥物和乙型肝炎疫苗的聯合 HK1041434A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9900630 1999-01-12
PCT/EP1999/010295 WO2000041463A2 (en) 1999-01-12 1999-12-21 Combination of hepatitis b vaccine with antiviral agents

Publications (1)

Publication Number Publication Date
HK1041434A1 true HK1041434A1 (zh) 2002-07-12

Family

ID=10845878

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02101211.9A HK1041434A1 (zh) 1999-01-12 2002-02-19 抗病毒藥物和乙型肝炎疫苗的聯合

Country Status (19)

Country Link
EP (1) EP1140163A2 (zh)
JP (1) JP2002534438A (zh)
KR (1) KR20010090011A (zh)
CN (1) CN1391482A (zh)
AR (1) AR022250A1 (zh)
AU (1) AU760574B2 (zh)
BR (1) BR9916893A (zh)
CA (1) CA2359110A1 (zh)
CO (1) CO5241355A1 (zh)
CZ (1) CZ20012544A3 (zh)
HK (1) HK1041434A1 (zh)
HU (1) HUP0105070A2 (zh)
IL (1) IL144186A0 (zh)
NO (1) NO20013337L (zh)
NZ (1) NZ512890A (zh)
PL (1) PL349347A1 (zh)
TR (1) TR200102024T2 (zh)
WO (1) WO2000041463A2 (zh)
ZA (1) ZA200105690B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999061056A2 (en) 1998-05-22 1999-12-02 Loeb Health Research Institute At The Ottawa Hospital Methods and products for inducing mucosal immunity
CN1560078B (zh) 1998-07-31 2011-06-22 株式会社国际癌症免疫研究所 基于癌抑制基因wt1的产物的癌抗原
CA2440303C (en) 2001-03-22 2013-03-19 Haruo Sugiyama Wt1 modified peptide
US8735357B2 (en) 2001-09-28 2014-05-27 International Institute Of Cancer Immunology, Inc. Method of inducing antigen-specific T cells
JPWO2003028758A1 (ja) * 2001-09-28 2005-01-13 治夫 杉山 抗原特異的ｔ細胞の誘導方法
MY131488A (en) * 2002-04-08 2007-08-30 Bristol Myers Squibb Co Low dose liquid entecavir formulations and use
PT2241325E (pt) 2002-10-29 2012-04-12 Coley Pharm Gmbh Utilização de oligonucleótidos cpg no tratamento de infecção com vírus da hepatite c
AU2003300919A1 (en) 2002-12-11 2004-06-30 Coley Pharmaceutical Gmbh 5' cpg nucleic acids and methods of use
CN100443117C (zh) * 2003-05-13 2008-12-17 深圳康泰生物制品股份有限公司 一种治疗性乙型肝炎的疫苗制剂、其制备方法及其用途
US8541167B2 (en) 2004-06-03 2013-09-24 Saint Louis University Methods and compositions for vaccination
AR065504A1 (es) * 2007-02-28 2009-06-10 Ct Ingenieria Genetica Biotech Terapia combinada para el tratamiento de la hepatitis b cronica. uso.
WO2020134682A1 (zh) * 2018-12-24 2020-07-02 南京远大赛威信生物医药有限公司 用于治疗乙型肝炎的药物制剂及其制备方法和用途
EP4321173A1 (en) * 2021-04-07 2024-02-14 Denka Company Limited Adjuvant activity enhancer and adjuvant composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2109921T3 (es) * 1989-07-25 1998-02-01 Smithkline Beecham Biolog Nuevos antigenos y procedimientos para su preparacion.
EP1064025B1 (en) * 1998-03-09 2006-09-13 GlaxoSmithKline Biologicals S.A. Combined vaccine compositions

Also Published As

Publication number Publication date
KR20010090011A (ko) 2001-10-17
TR200102024T2 (tr) 2001-12-21
EP1140163A2 (en) 2001-10-10
CZ20012544A3 (cs) 2002-01-16
AR022250A1 (es) 2002-09-04
JP2002534438A (ja) 2002-10-15
NO20013337L (no) 2001-08-17
WO2000041463A3 (en) 2000-11-09
PL349347A1 (en) 2002-07-15
IL144186A0 (en) 2002-05-23
ZA200105690B (en) 2002-09-25
NO20013337D0 (no) 2001-07-05
WO2000041463A2 (en) 2000-07-20
AU2100900A (en) 2000-08-01
CA2359110A1 (en) 2000-07-20
CO5241355A1 (es) 2003-01-31
NZ512890A (en) 2003-09-26
BR9916893A (pt) 2001-11-20
HUP0105070A2 (hu) 2002-04-29
AU760574B2 (en) 2003-05-15
CN1391482A (zh) 2003-01-15

Similar Documents

Publication Publication Date Title
IL144171A0 (en) Quinolinecarboxamides as antiviral agents
EP1187827A4 (en) ANTIVIRAL ACTIVE SUBSTANCE
HK1052878A1 (zh) 利巴傳林-聚乙二醇化干擾素α：丙型肝炎病毒的聯合治療
IL145045A0 (en) Vaccine
HUS1300072I1 (hu) Vakcina
HK1039278B (zh) PEG化的干擾素-α-CCR5拮抗劑組合HIV療法
HK1041434A1 (zh) 抗病毒藥物和乙型肝炎疫苗的聯合
GB9826069D0 (en) HIV vaccine
GB9906815D0 (en) Anti-neoplastic viral agents
IL162236A0 (en) Purified hepatitis c virus envelopeproteins for dagnostic and therapeutic use
HK1045324A1 (zh) 病毒變體
GB9915204D0 (en) Vaccine
IL139269A0 (en) Hepatitis vaccine
GB9906437D0 (en) Vaccine
EP1290230A4 (en) HEPATITIS C VIRUS CONJUGATE
GB9913327D0 (en) Vaccine
AP2001002076A0 (en) Hiv vaccine
GB9927353D0 (en) Virus preparation and use
GB9928165D0 (en) Baby sling
GB9917981D0 (en) Viral vaccine
GB0012497D0 (en) Antiviral therapy
GB9909072D0 (en) Vaccine
IL128154A0 (en) Conjugates of antiviral nucleosides
GB0030102D0 (en) HCV vaccines
GB0030789D0 (en) HCV vaccines